|
Phase II COVID-19 Vaccines
This site presents COVID-19 vaccines that are currently in Phase II clinical trials as of February 17, 2021.
Current Phase II COVID-19 vaccines include:
- AdCLD-CoV19
- Clinical trial ID:
- Phase I/II: NCT04666012
- Age subgroups: 19-64 years
- Location: South Korea
- Type: Recombinant vector vaccine
- Manufacturer: Cellid Co., Ltd.
- VIOLIN: 5800
- VO: VO_0004996
- AKS-452
- Clinical trial ID:
- Phase I/II: NCT04681092
- Age subgroups: 18-55 years
- Location: Netherlands
- Type: Subunit vaccine
- Manufacturer: University Medical Center Groningen, Akston Biosciences Inc.
- VIOLIN: 5834
- VO: VO_0004999
- ARCT-021
- Other names: LUNAR-COV19
- Clinical trial ID:
- Phase II: NCT04728347
- Age subgroups: 21-80 years
- Location: Singapore
- Phase I/II: NCT04480957
- Age subgroups:
- Phase I: 21-55 years
- Phase II: 21-55 years, 56-80 years
- Location: Singapore
- Type: mRNA vaccine
- Manufacturer: Arcturus Therapeutics, Duke-NUS Medical School
- VIOLIN: 5781
- VO: VO_0005164
- AV-COVID-19
- Clinical trial ID:
- Phase I/II: NCT04386252
- Age subgroups: 18 years and older
- Location: USA
- Type: Recombinant vector vaccine
- Manufacturer: Aivita Biomedical, Inc.
- VIOLIN: 5801
- VO: VO_0005079
- BECOV2A
- Clinical trial ID:
- Phase I/II: CTRI/2020/11/029032
- Age subgroups:
- Phase I: 18-55 years
- Phase II: 18-65 years
- Location: India
- Type: Subunit vaccine
- Manufacturer: Biological E
- VIOLIN: 5802
- VO: VO_0005081
- CIGB-66
- Clinical trial ID:
- Type: Subunit vaccine
- Manufacturer: Center for Genetic Engineering and Biotechnology (CIGB)
- VIOLIN: 5803
- VO: VO_0005082
- CIGB-669
- Clinical trial ID:
- Type: Subunit vaccine
- Manufacturer: Center for Genetic Engineering and Biotechnology (CIGB)
- VIOLIN: 5804
- VO: VO_0005083
- COVAC
- Clinical trial ID:
- Phase I/II: NCT04702178
- Age subgroups: 18-54 years, 55-69 years, 70 years and above
- Location: Canada
- Type: Subunit vaccine
- Manufacturer: Vaccine and Infectious Disease Organization (VIDO), SEPPIC, Vaccine Formulation Institute (VFI)
- COVID-19 inactivated virus vaccine by Shenzhen Kangtai Biological Products
- Clinical trial ID:
- Type: Inactivated or "killed" vaccine
- Manufacturer: Shenzhen Kangtai Biological Products Co., Ltd.
- VIOLIN: 5805
- VO: VO_0005084
- COVID-19 protein subunit vaccine by Sanofi and GSK
- Clinical trial ID:
- Phase I/II: NCT04537208
- Age subgroups: 18-49 years, 50 years and above
- Location: USA
- Type: Subunit vaccine
- Manufacturer: Sanofi Pasteur, GSK
- VIOLIN: 5833
- VO: VO_0005085
- DelNS1-2019-nCoV-RBD-OPT1
- Clinical trial ID:
- Type: Recombinant vector vaccine
- Manufacturer: Beijing Wantai Biological Pharmacy, Xiamen University
- VIOLIN: 5806
- VO: VO_0005087
- GBP510
- Clinical trial ID:
- Phase I/II: NCT04750343
- Age subgroups:
- Phase I: 19-55 years
- Phase II: 19-85 years
- Location: South Korea
- Type: Subunit vaccine
- Manufacturer: SK Bioscience Co., Ltd.
- VIOLIN: 5831
- GLS-5310
- Clinical trial ID:
- Phase I/II: NCT04673149
- Age subgroups:
- Phase I: 19-50 years
- Phase II: 19-65 years
- Location: South Korea
- Type: DNA vaccine
- Manufacturer: GeneOne Life Science, Inc.
- VIOLIN: 5807
- VO: VO_0005089
- GX-19
- Clinical trial ID:
- Phase I/II: NCT04715997
- Age subgroups: 18-55 years
- Location: South Korea
- Phase I/II: NCT04445389
- Age subgroups: 18-50 years
- Location: South Korea
- Type: DNA vaccine
- Manufacturer: Genexine
- VIOLIN: 5788
- VO: VO_0005170
- IIBR-100
- Other names: BriLife
- Clinical trial ID:
- Phase I/II: NCT04608305
- Age subgroups:
- Phase I: 18-55 years
- Phase II: 18-55 years, 56-85 years
- Location: Israel
- Type: Recombinant vector vaccine
- Manufacturer: Israel Institute for Biological Research, Weizmann Institute of Science
- VIOLIN: 5799
- VO: VO_0005090
- KBP-COVID-19
- Clinical trial ID:
- Phase I/II: NCT04473690
- Age subgroups: 18-49 years, 50-70 years
- Type: Subunit vaccine
- Manufacturer: Kentucky BioProcessing
- VIOLIN: 5792
- VO: VO_0005171
- LV-SMENP-DC
- Clinical trial ID:
- Phase I/II: NCT04276896
- Age subgroups: 6 months to 80 years
- Location: China
- Type: Recombinant vector vaccine
- Manufacturer: Shenzhen Geno-Immune Medical Institute
- VIOLIN: 5808
- VO: VO_0005091
- MVC-COV1901
- Clinical trial ID:
- Phase II: NCT04695652
- Age subgroups: 20-64 years, 65 years and above
- Location: Taiwan, Vietnam
- Type: Subunit vaccine
- Manufacturer: Medigen; Dynavax
- VIOLIN: 5828
- VO: VO_0005192
- Nanocovax
- Clinical trial ID:
- Phase I/II: NCT04683484
- Age subgroups:
- Phase I: 18-50 years
- Phase II: 12-75 years
- Location: Vietnam
- Type: Subunit vaccine
- Manufacturer: Nanogen Pharmaceutical Biotechnology
- VIOLIN: 5809
- VO: VO_0005092
- QazCovid-in
- Clinical trial ID:
- Phase II: NCT04530357
- Age subgroups:
- Phase I: 18-50 years
- Phase II: 18 years and above
- Location: Kazakhstan
- Type: Inactivated or "killed" vaccine
- Manufacturer: Research Institute for Biological Safety Problems, National Scientific Center for Phthisiopulmonology of the Republic of Kazakhstan
- VIOLIN: 5810
- VO: VO_0005093
- RBD-HBsAg VLP
- Clinical trial ID:
- Phase I/II: ACTRN12620000817943
- Age subgroups:
- Phase I: 18-45 years
- Phase II: 18-79 years
- Location: Australia
- Type: Virus Like Particle
- Manufacturer: Serum Institute of India, Accelegen Pty
- VIOLIN: 5811
- VO: VO_0005094
- Recombinant SARS-CoV-2 vaccine (Sf9 cell)
- Clinical trial ID:
- Phase II: NCT04640402
- Age subgroups: 18-59 years, 60 years and above
- Location: China
- Phase II: NCT04718467
- Age subgroups: 18-59 years, 60 years and above
- Location: China
- Type: Subunit vaccine
- Manufacturer: West China Hospital, Sichuan University
- VIOILN: 5812
- VO: VO_0005095
- S-268019
- Clinical trial ID:
- Type: Subunit vaccine
- Manufacturer: Shionogi
- VIOLIN: 5813
- VO: VO_0005096
- Soberana
- Clinical trial ID:
- Phase I/II: IFV/COR/04
- Age subgroups: 19-59 years, 60-80 years
- Location: Cuba
- Phase II: IFV/COR/08
- Age subgroups: 19-80 years
- Location: Cuba
- Type: Subunit vaccine
- Manufacturer: Instituto Finlay de Vacunas, Cuba
- VIOLIN: 5814
- VO: VO_0005097
- VLA2001
- Clinical trial ID:
- Phase I/II: NCT04671017
- Age subgroups: 18-55 years
- Location: UK
- Type: Inactivated or "killed" vaccine
- Manufacturer: Valneva, National Institute for Health Research (UK)
- VIOLIN: 5816
- VO: VO_0005099
- ZyCoV-D
- Clinical trial ID:
- Phase I/II: CTRI/2020/07/026352
- Age subgroups:
- Phase I: 18-45 years
- Phase II: 18-79 years
- Location: Australia
- Type: DNA vaccine
- Manufacturer: Zydus Cadila
- VIOLIN: 5778
- VO: VO_0005162
Provenance: All data in Cov19VaxKB originates from manual curation of reliable resources
Note: The page was updated on February 17, 2021. We plan to update this page on a weekly or even a daily basis. Please provide us with any new information that you believe would be useful if included on the website.
|